Finally, since several subpopulations of CD8+ T cells varied according to the different EBV infection statuses, we decided to evaluate whether there were differences in the percentages of these populations across the different latency profiles, as well as their correlation with LMP1 and EBNA2. The gene discussed is CD8A; the disease is Epstein-Barr virus infection.